Applied DNA Sciences (NASDAQ:APDN) Receives New Coverage from Analysts at StockNews.com

StockNews.com started coverage on shares of Applied DNA Sciences (NASDAQ:APDN) in a research report released on Saturday. The brokerage issued a sell rating on the technology company’s stock.

Separately, HC Wainwright cut their price objective on Applied DNA Sciences from $7.00 to $1.50 and set a buy rating for the company in a research note on Monday, June 10th.

Applied DNA Sciences Trading Down 19.2 %

APDN opened at $0.44 on Friday. The firm’s 50 day simple moving average is $1.83 and its two-hundred day simple moving average is $7.64. The company has a market capitalization of $431,298.00, a PE ratio of -0.03 and a beta of 0.09. Applied DNA Sciences has a 1-year low of $0.37 and a 1-year high of $37.20.

Applied DNA Sciences (NASDAQ:APDN) last announced its earnings results on Friday, May 10th. The technology company reported ($5.31) EPS for the quarter, missing analysts’ consensus estimates of ($4.60) by ($0.71). Applied DNA Sciences had a negative return on equity of 306.32% and a negative net margin of 222.33%. The company had revenue of $0.93 million during the quarter, compared to the consensus estimate of $0.90 million. Equities analysts forecast that Applied DNA Sciences will post -2.95 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Applied DNA Sciences

An institutional investor recently bought a new position in Applied DNA Sciences stock. Silverberg Bernstein Capital Management LLC bought a new position in shares of Applied DNA Sciences, Inc. (NASDAQ:APDN) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 98,301 shares of the technology company’s stock, valued at approximately $61,000. Silverberg Bernstein Capital Management LLC owned approximately 0.72% of Applied DNA Sciences at the end of the most recent quarter. 22.22% of the stock is owned by institutional investors.

Applied DNA Sciences Company Profile

Applied DNA Sciences, Inc, a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services.